All Articles

Supermicro's new end-to-end blueprint, powered by NVIDIA's Rubin platform, isn't just about speed. It's a strategic play to solve AI's biggest crisis: power.

Intellicheck’s entry into the Russell 2000 validates its growth. But what does this mean for investors and the broader fight against digital identity fraud?

LendingClub completes its transformation into Happen Bank, a strategic pivot years in the making. What does this mean for investors, consumers, and the future of digital banking?

After shedding its ammo business and costly legal battles, Outdoor Holding Co. is doubling down on its GunBroker.com platform with AI to drive growth.

The ultra-luxury automaker's new CFO, Scott Durbin, brings a history of massive fundraising in biotech—a strategic hire signaling a major capital push.

Leveraging the World Cup stage, Dove's #TheGameIsOurs campaign confronts a silent crisis: why nearly half of girls quit sports due to body criticism.

With regulatory approval for its $218M deal, Firm Capital deepens its push into manufactured housing, a key affordable housing segment in Western Canada.

When Cvent faced a massive M&A challenge, it turned to AI. The result? A shift from legal bottleneck to strategic powerhouse. Here’s how they did it.

ToonieBet's new partnership with the Hamilton Tiger-Cats is not just a sponsorship. It's a calculated move in Ontario's $66B iGaming arena. Here's why.

The dairy industry is betting big, tying its future to Supergirl. But is this blockbuster partnership a genuine growth signal or just super-powered marketing hype?

Refinity's new license to turn plastic waste into jet fuel is more than a green initiative; it's a calculated move to rewire petrochemical supply chains.

With a pivotal drug approval on the horizon, Spruce Biosciences' appointment of a rare disease veteran signals a critical transition from R&D to commercial reality.

A CAD$40M military contract validates NorthStar's space tech, bolsters Canada's sovereignty, and fuels its high-stakes journey to the public market.

Genius Group's massive share repurchase program aims to boost shareholder value, but a look at its financials reveals a high-stakes gamble. Is this a confident bet or a red flag?

Praxis Precision Medicines' elsunersen earns Breakthrough Therapy status, signaling a major step toward the first disease-modifying treatment for SCN2A-DEE.

With new CEO Eric Augustyn, an active investor from its own ranks, BiggerPockets plans a major platform overhaul to fortify its market dominance.

GuideAI Health's new AI software, which scans for peripheral vascular disease, promises to slash diagnosis times and prevent amputations for millions.

Veea Inc. bolsters its leadership to capture the booming edge AI market, but can seasoned executives overcome daunting financial hurdles and fierce competition?

With 1 in 4 seniors facing isolation, Element Care is using a $100K grant to prove that belonging is a clinical imperative, not just a 'nice-to-have'.

Block Reign's CertiK audit for the Gnodi blockchain signals a new era of corporate-backed transparency in decentralized ecosystems, aiming for real-world utility.